Effect of selective phosphodiesterase type IV inhibitor, rolipram, on fluid and cellular phases of inflammatory response. [electronic resource]
Producer: 19930818Description: 333-44 p. digitalISSN:- 0360-3997
- 3',5'-Cyclic-AMP Phosphodiesterases
- Animals
- Anti-Inflammatory Agents, Non-Steroidal -- pharmacology
- Arachidonic Acid -- toxicity
- Calcimycin -- pharmacology
- Cells, Cultured
- Colforsin -- pharmacology
- Cyclic Nucleotide Phosphodiesterases, Type 4
- Ear, External
- Eicosanoids -- metabolism
- Histamine Release -- drug effects
- Humans
- Imidazoles -- pharmacology
- Inflammation -- chemically induced
- Leukotriene B4 -- biosynthesis
- Male
- Mast Cells -- drug effects
- Mice
- Mice, Inbred BALB C
- Monocytes -- drug effects
- Nadolol -- pharmacology
- Naproxen -- pharmacology
- Neutrophils -- drug effects
- Phosphodiesterase Inhibitors -- pharmacology
- Phosphoric Diester Hydrolases -- physiology
- Purinones -- pharmacology
- Pyrazoles -- pharmacology
- Pyrrolidinones -- pharmacology
- Receptors, Adrenergic, beta -- drug effects
- Rolipram
- SRS-A -- metabolism
- Thiazoles -- pharmacology
No physical items for this record
Publication Type: Comparative Study; Journal Article
There are no comments on this title.
Log in to your account to post a comment.